Topics

Latest "The Hillman Company & Hillman Family Foundations" News Stories - Page: 5

12:50 EST 20th November 2019 | BioPortfolio

Here are the most relevant search results for "The Hillman Company & Hillman Family Foundations" found in our extensive news archives from over 250 global news sources.

More Information about The Hillman Company & Hillman Family Foundations on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about The Hillman Company & Hillman Family Foundations for you to read. Along with our medical data and news we also list The Hillman Company & Hillman Family Foundations Clinical Trials, which are updated daily. BioPortfolio also has a large database of The Hillman Company & Hillman Family Foundations Companies for you to search.

Showing "Hillman Company Hillman Family Foundations" News Articles 101–125 of 12,000+

Tuesday 19th November 2019

Epigenomics AG Reports Financial Results for the First Nine Months 2019

DGAP-News: Epigenomics AG / Key word(s): Quarterly / Interim Statement/9 Month figures 19.11.2019 / 08:00 The issuer is solely responsible for the content of this announcement. Epigenomics AG Reports Financial Results for the First Nine Months 2019   Berlin (Germany) and San Diego, CA (USA), November 19, 2019 - Epigenomics AG (FSE: ECX, OTCQX: EPGNY, the "Company")...


Emergent Health Corp. (OTC PINK:EMGE) Announces New Evidence That Chronic Kidney Disease and Renal Dialysis Time May Be Reduced or Reversed

KING OF PRUSSIA, PA / ACCESSWIRE / November 19, 2019 / Chronic Kidney Disease (CKD) is a world-wide affliction. Many CKD patients find they can not survive without the life-saving procedure known as dialysis. Dialysis is a multi-billion dollar industry with companies such as Davita, Inc. (DVA: NYSE) and Fresenius Kidney Care, a private company, who are leaders in this field dominating this market....

Following Brain Injury, Artist Rediscovers The World Through a Child’s Eyes

SANGERFIELD, N.Y. (PRWEB) November 19, 2019 It was an ordinary springtime evening in 2000 when Bernie Freytag was training for his first marathon with a bike ride along the Charles River in Boston. Days later, Bernie woke up in Massachusetts General Hospital, surrounded by friends and family...


Monday 18th November 2019

Choosing family over medicine: Why I decided to leave clinical medicine

When my obstetrician told me I was not going back to my clinic that afternoon due to severe preeclampsia, I was so indoctrinated that my first thought was of the inconvenience to my patients who would need to be rescheduled. Only a few minutes later did it register that I would be giving birth sooner […] Find jobs at Careers by KevinMD.com. Search thousands of physician, PA, NP, and CRNA j...

Amidst Novartis Takeover Rumors, The Medicines Company Announces Positive Cholesterol Data

Amidst rumors that Novartis might be interested in an acquisition, The Medicines Company announced data from ORION-10, the second of three 19-month Phase III trials of inclisiran for lowering cholesterol.

'A Clever Bit of Chemistry': NuCana CEO Speaks on Company's Biliary Tract Cancer Drug

If successful, the CEO told BioSpace in an exclusive interview that Acelarin will break the glass ceiling as the first FDA-approved treatment for biliary tract cancer.

Athenex Announces Key Company Activities at San Antonio Breast Cancer Symposium

Abstract selected for the SABCS press programOral presentation of Oral Paclitaxel and encequidar Phase III results on December 13Company to host a Key Opinion Leader webcast event for the investment community BUFFALO, N.Y., Nov. 19, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of n...

Avante Health Solutions Announces Recent Management Changes

Sterling Peloso, President of Avante Ultrasound, has assumed operating responsibilities of Avante Patient Monitoring. CHICAGO (PRWEB) November 18, 2019 Avante Health Solutions (“Avante”) is pleased to announce that Mr. Sterling Peloso, President of Avante Ultrasound, has assumed the operating responsibilities of Avante Patient Monitoring. This expanded role will be in addition to his current ...

Western Dental and the SoCal Chapter of the NFL Alumni Provide Free Turkey Dinners

Western Dental & Orthodontics, one of the nation’s leaders in accessible, affordable oral healthcare and the leading orthodontics provider in the country, has joined with the Southern California NFL Alumni and Zoe Christian Fellowship in their annual Turkey Giveaway. Under the partnership, Western Dental will provide volunteers and food donations for 300 families in need in the Southern C...

Online Pharmacy eDrugstore Joins Inc 5000

Veteran online drugstore joins Inc 5000 with corporate parent Secure Medical Tempe, Arizona-based Secure Medical, parent company of eDrugstore.com, joined the Inc 5000 in August, after experiencing 62% revenue growth from 2015 to 2018. The Inc 5000 is for U.S.-based, privately held, independent, for-profit businesses that have shown impressive revenue growth. The growth of Secure Medical and i...

TissueTech Announces Appointment of New Chief Commercial Officer - Thomas (Tom) Williamson tapped to provide strategic oversight of sales and marketing as the company continues to expand its commercialization efforts

Miami, Fla. – November 18, 2019 – TissueTech, Inc., a pioneer in the development and clinical application of regenerative human birth tissue products marketed through its subsidiaries Bio-Tissue, Inc. and Amniox Medical, Inc., announced this week the appointment of Tom Williamson to the position of Chief Commercial Officer (CCO) to support the continued strategic expansion of its mar...

Injectable inclisiran (siRNA) as 3rd anti-PCSK9 behind mAbs Repatha and Praluent

Injectable inclisiran (siRNA) as 3rd anti-PCSK9 behind mAbs Repatha and Praluent   Reporter: Aviva Lev-Ari, PhD, RN Next stop, filing for approval. The Medicines Company has said it plans to submit inclisiran for FDA review by the end of 2019 and EMA review in the first quarter of 2020. If the drug’s approved it’ll be […]

Researchers Present New Positive Interim Data on Appili Therapeutics’ ATI-1701 Biodefense Program at 2019 Chemical and Biological Defense Science & Technology Conference

New data demonstrate durable protective response for Appili’s vaccine candidate against Francisella tularensis, a Category A pathogen and potential biological weapons threat Presentation provides additional safety and efficacy data supporting use of ATI-1701 as a medical countermeasure, supports ongoing development under U.S. Food and Drug Administration’s medical countermeasure development...

Intellipharmaceutics International Inc.: Intellipharmaceutics Closes USD$250,000 Convertible Debenture Financing with Drs. Isa and Amina Odidi

TORONTO, ON / ACCESSWIRE / November 18, 2019 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company") and Drs. Isa and Amina Odidi announce tha...

TFF Pharmaceuticals to Ring NASDAQ Stock Market Opening Bell on Wednesday, November 20, 2019

The clinical-stage biopharma company celebrates its successful $22 million IPO TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, an

FDA Grants Orphan Drug Designation to Axovant Gene Therapies’ Investigational Treatment for GM1 Gangliosidosis

NEW YORK and BASEL, Switzerland, Nov. 18, 2019 (GLOBE NEWSWIRE) — Axovant Gene Therapies Ltd. (NASDAQ: AXGT), a clinical-stage company developing innovative gene therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the Company’s investigational gene therapy, AXO-AAV-GM1, for the treatment of GM1 gangliosidosis. GM1 gangliosidos...

Caribou Biosciences Announces New Methods to Harness Type I CRISPR-Cas Systems for Genome Engineering in Human Cells

Findings Released Today in Nature Biotechnology Caribou Biosciences, Inc., a leading CRISPR genome editing company, announced the publication of a new study demonstrating human genome engineering with Type I CRISPR-Cas systems. The study, entitled “Harnessing Type I CRISPR-Cas Systems for Genome Engineering in Human Cells,” was published today in the peer-reviewed scientific journal Nature B...

Rating End-of-Life Care After Stopping Dialysis

(MedPage Today) -- Study Authors: Claire A. Richards, Paul L. Hebert, et al.; Channing E. Tate, Daniel D. Matlock Target Audience and Goal Statement: Nephrologists, geriatricians, internists, primary care physicians, family medicine specialists...

Climate Change: Is Addressing It Part of the Doctor's Job?

]]>(MedPage Today) -- SAN DIEGO – Physicians have a moral imperative to persuade their patients, their family members and friends -- and especially their health system leaders -- that climate change is real, with global health impacts already...

CDK4/6 Inhibitor/Endocrine Tx Improves PFS Over Chemo in Premenopausal Breast Cancer

(MedPage Today) -- Study Authors: Yeon Hee Park, Tae-Yong Kim, et al.; Marie Robert, Nicholas Turner Target Audience and Goal Statement: Oncologists, women's health specialists, internists, primary care physicians, family medicine specialists...

Intellipharmaceutics Closes USD$250,000 Convertible Debenture Financing with Drs. Isa and Amina Odidi

TORONTO, ON / ACCESSWIRE / November 18, 2019 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company") and Drs. Isa and Amina Odidi announce that, following the close of markets on November 15, 2019, the Company issued to Drs. Isa and Amina Odidi, by way of private placement, an unsecured convertible debenture of the Company ...

Older adults and wearable activity trackers

For older adults, wearable activity trackers may be popular gifts, but they may not be used for very long. While counterintuitive, engaging in competition with family and friends decreases the odds of long-term use among older adults, perhaps because they feel it's demotivating, according to a new study.

NowRx Partners with Parata Systems to Significantly Streamline Pharmacist Verification, Increase Accuracy

On-demand, free delivery pharmacy integrates revolutionary pharmacy automation and image capture technology; industry-first process increases verification efficiency, accuracy and delivery speed of prescription medications MOUNTAIN VIEW, Calif. and DURHAM, N.C. (PRWEB) November 18, 2019 NowRx, the same-day, free-delivery pharmacy, and Parata, a leader in automated dispensing with high speed and a...

ARS Treatment Centers Continues to Expand in Virginia With New Office-Based Opioid Treatment Facility in Winchester

National leader advances its commitment to provide needed resources to strengthen Virginia communities ARS Treatment Centers, a category leader in Office-Based Opioid Treatment (OBOT), announced today that it has opened a new clinic in Winchester, VA. The new facility is a part of the company’s new network of local clinics that provide critical treatment resources to combat the opioid crisis a...

Rapidly Growing - Spero Health Opens Cookeville Clinic to Address Drug Epidemic

Spero Health, a CARF-accredited organization and leader in outpatient addiction treatment, has announced the opening of a new clinic in Cookeville, Tennessee. The Cookeville Spero Health Clinic located at 225 N Willow Ave. will open on Friday, November 22nd and will begin seeing patients that day. For more information or to schedule an immediate appointment, individuals are encouraged to call the...


Quick Search

News Quicklinks